1403 related articles for article (PubMed ID: 15880830)
1. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
[TBL] [Abstract][Full Text] [Related]
2. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.
Kirou KA; Lee C; George S; Louca K; Papagiannis IG; Peterson MG; Ly N; Woodward RN; Fry KE; Lau AY; Prentice JG; Wohlgemuth JG; Crow MK
Arthritis Rheum; 2004 Dec; 50(12):3958-67. PubMed ID: 15593221
[TBL] [Abstract][Full Text] [Related]
3. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP
Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus.
Landolt-Marticorena C; Bonventi G; Lubovich A; Ferguson C; Unnithan T; Su J; Gladman DD; Urowitz M; Fortin PR; Wither J
Ann Rheum Dis; 2009 Sep; 68(9):1440-6. PubMed ID: 18772188
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
6. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
[TBL] [Abstract][Full Text] [Related]
8. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
[TBL] [Abstract][Full Text] [Related]
9. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.
Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD;
Arthritis Rheum; 2006 Oct; 55(5):799-806. PubMed ID: 17013840
[TBL] [Abstract][Full Text] [Related]
10. Clinical and serologic factors associated with lupus pleuritis.
Mittoo S; Gelber AC; Hitchon CA; Silverman ED; Pope JE; Fortin PR; Pineau C; Smith CD; Arbillaga H; Gladman DD; Urowitz MB; Zummer M; Clarke AE; Bernatsky S; Hudson M; Tucker LB; Petty RE; ; Peschken CA
J Rheumatol; 2010 Apr; 37(4):747-53. PubMed ID: 20110526
[TBL] [Abstract][Full Text] [Related]
11. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.
Lee YH; Kim YR; Ji JD; Sohn J; Song GG
J Rheumatol; 2001 Sep; 28(9):2008-11. PubMed ID: 11550967
[TBL] [Abstract][Full Text] [Related]
12. Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus.
Biesen R; Demir C; Barkhudarova F; Grün JR; Steinbrich-Zöllner M; Backhaus M; Häupl T; Rudwaleit M; Riemekasten G; Radbruch A; Hiepe F; Burmester GR; Grützkau A
Arthritis Rheum; 2008 Apr; 58(4):1136-45. PubMed ID: 18383365
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
Reichlin M; Broyles TF; Hubscher O; James J; Lehman TA; Palermo R; Stafford HA; Taylor-Albert E; Wolfson-Reichlin M
Arthritis Rheum; 1999 Jan; 42(1):69-75. PubMed ID: 9920016
[TBL] [Abstract][Full Text] [Related]
14. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus.
Jacobi AM; Odendahl M; Reiter K; Bruns A; Burmester GR; Radbruch A; Valet G; Lipsky PE; Dörner T
Arthritis Rheum; 2003 May; 48(5):1332-42. PubMed ID: 12746906
[TBL] [Abstract][Full Text] [Related]
15. Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells.
Karonitsch T; Feierl E; Steiner CW; Dalwigk K; Korb A; Binder N; Rapp A; Steiner G; Scheinecker C; Smolen J; Aringer M
Arthritis Rheum; 2009 May; 60(5):1463-71. PubMed ID: 19404947
[TBL] [Abstract][Full Text] [Related]
16. Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus.
Nikpour M; Dempsey AA; Urowitz MB; Gladman DD; Barnes DA
Ann Rheum Dis; 2008 Aug; 67(8):1069-75. PubMed ID: 18063674
[TBL] [Abstract][Full Text] [Related]
17. Mannose-binding lectin is a disease-modifying factor in North American patients with systemic lupus erythematosus.
Piao W; Liu CC; Kao AH; Manzi S; Vogt MT; Ruffing MJ; Ahearn JM
J Rheumatol; 2007 Jul; 34(7):1506-13. PubMed ID: 17610319
[TBL] [Abstract][Full Text] [Related]
18. Lupus-like disease and high interferon levels corresponding to trisomy of the type I interferon cluster on chromosome 9p.
Zhuang H; Kosboth M; Lee P; Rice A; Driscoll DJ; Zori R; Narain S; Lyons R; Satoh M; Sobel E; Reeves WH
Arthritis Rheum; 2006 May; 54(5):1573-9. PubMed ID: 16645992
[TBL] [Abstract][Full Text] [Related]
19. [Interferon-inducible genes lymphocyte antigen 6 complex E and tetratricopeptide repeats 1 are correlated with clinical features of patients with systemic lupus erythematosus].
Tang JP; Gu YY; Shen N; Ye S; Qian J; Hua J; Chen XG; Chen SL; Bao CD; Wang Y; Zhang W
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1157-60. PubMed ID: 15387975
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
